Institute of Organic and Pharmaceutical Chemistry
The National Hellenic Research Foundation
Research
Publications
People
Alumni
Facilities
PDB
Vacancies
Contact Us
Links
The Structural Biology and Chemistry Group (SBCG) was established in 1979 by Dr. Nikos G. Oikonomakos.
The general theme that underlies the work of SBCG is macromolecular structural biology and chemistry in which structures are used as the starting point for further studies on the mechanisms of catalysis, mechanisms of inhibition, regulation, molecular recognition, and structure-based drug design.
Currently our activities are directed to research on a high-throughput structure-assisted (or protein-ligand interaction) approach in drug discovery based on the combination of target structural information with parallel chemistry and molecular dynamics simulations. At present, the structures of individual biological macromolecules are studied in much detail and with a defined scientific question in mind. While this approach will certainly be continued, the new method of high-throughput in the field of structural genomics is emerging. Advances in docking and virtual ligand screening, computational chemistry and design, parallel chemistry along with technical developments in X-ray crystallography (automation in crystallogenesis, data collection in synchrotron radiation sites, data processing, and structure determination) has a major impact on functional analysis and high-throughput structure-assisted drug design. High-throughput X-ray crystallography is advancing the productivity of drug discovery by optimising drug candidates with the molecular target of interest.
Research Interests:
Control of glycogen metabolism
Phosphoenolpyruvate carboxykinase
Carbohydrate
recognition
Human TAFs9 proteins
Xylanases and feruloyl esterases